Zacks Investment Research on MSN
Can CorMedix's Melinta acquisition aid growth beyond DefenCath?
CorMedix CRMD took a major step to diversify its revenue base and lessen reliance on its lead marketed product, DefenCath ...
THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for ...
The final, formatted version of the article will be published soon. Introduction: Reperfusion injury remains a major limitation in the management of ST-segment elevation myocardial infarction (STEMI).
Introduction: Reperfusion injury remains a major limitation in the management of ST-segment elevation myocardial infarction (STEMI). Despite numerous preclinical successes, cardioprotective strategies ...
BETHLEHEM, Pa., July 18, 2025 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections ...
Deep vein thrombosis is a severe and life-threatening disease caused by the formation of a blood clot in the deep veins, usually in the legs. The conventional treatment consists of injections of the ...
Science, founded by Thomas A. Edison in 1880 and published by AAAS, today ranks as the world's largest circulation general science journal. Published 51 times a year, Science is renowned for its ...
BALTIMORE - Thousands of miles from a manufacturing plant in China, where the key active ingredient in heparin is sourced, Wanda Crowell receives a daily infusion of the drug in her bed at Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results